- Home
- NIM vs NSPR Comparison
NIM vs NSPR Comparison
Compare NIM & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIM
- NSPR
- Stock Information
- Founded
- NIM 1992
- NSPR 2005
- Country
- NIM United States
- NSPR United States
- Employees
- NIM N/A
- NSPR N/A
- Industry
- NIM Trusts Except Educational Religious and Charitable
- NSPR Medical/Dental Instruments
- Sector
- NIM Finance
- NSPR Health Care
- Exchange
- NIM Nasdaq
- NSPR Nasdaq
- Market Cap
- NIM 116.0M
- NSPR 99.7M
- IPO Year
- NIM N/A
- NSPR N/A
- Fundamental
- Price
- NIM $9.35
- NSPR $1.95
- Analyst Decision
- NIM
- NSPR Strong Buy
- Analyst Count
- NIM 0
- NSPR 2
- Target Price
- NIM N/A
- NSPR $4.50
- AVG Volume (30 Days)
- NIM 35.4K
- NSPR 119.5K
- Earning Date
- NIM 01-01-0001
- NSPR 11-04-2025
- Dividend Yield
- NIM 3.46%
- NSPR N/A
- EPS Growth
- NIM N/A
- NSPR N/A
- EPS
- NIM N/A
- NSPR N/A
- Revenue
- NIM N/A
- NSPR $7,779,000.00
- Revenue This Year
- NIM N/A
- NSPR $7.48
- Revenue Next Year
- NIM N/A
- NSPR $104.39
- P/E Ratio
- NIM N/A
- NSPR N/A
- Revenue Growth
- NIM N/A
- NSPR 14.04
- 52 Week Low
- NIM $8.28
- NSPR $1.77
- 52 Week High
- NIM $9.74
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- NIM 51.87
- NSPR 22.72
- Support Level
- NIM $9.19
- NSPR $2.05
- Resistance Level
- NIM $9.42
- NSPR $2.40
- Average True Range (ATR)
- NIM 0.10
- NSPR 0.15
- MACD
- NIM 0.00
- NSPR -0.03
- Stochastic Oscillator
- NIM 52.00
- NSPR 29.05
About NIM Nuveen Select Maturities Municipal Fund
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its primary investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital. Its secondary investment objective is to enhance portfolio value relative to the municipal bond market through investments in tax-exempt municipal obligations that are underrated or undervalued, or that represent municipal market sectors that are undervalued.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.